Global Malaria Vaccines Market Analysis 2024 – Estimated Market Size And Key Drivers

 The Malaria Vaccines Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Malaria Vaccines Market:
https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

According to The Business Research Company’s Malaria Vaccines Global Market Report 2024, The malaria vaccines market size has grown exponentially in recent years. It will grow from $3.48 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 35.2%.  The  growth in the historic period can be attributed to high malaria burden, global health initiatives, funding and grants, malaria control programs, government support and regulatory frameworks.

The malaria vaccines market size is expected to see exponential growth in the next few years. It will grow to $15.32 billion in 2028 at a compound annual growth rate (CAGR) of 34.3%.  The growth in the forecast period can be attributed to global elimination goals, expanded access programs, increasing vaccine coverage, global vaccine alliances, climate change impact. Major trends in the forecast period include technological innovations, public-private partnerships, international collaboration, advancements in vaccine technology, advancements in vaccine technology.

A rise in the incidence of mosquito-related diseases is expected to propel the growth of the malaria vaccine market going forward. Mosquito-related diseases are a broad category of illnesses spread by the bite of an infected mosquito. The malaria vaccine, particularly the RTS, S/AS01 (RTS, S) vaccine, is used to prevent and reduce the impact of mosquito-borne infectious diseases by training the immune system to recognize and attack the parasite. For instance, in November 2023, according to a report published by the World Health Organization, a Switzerland-based intergovernmental organization, estimated 249 million cases of malaria occurred globally in 2022, with an increase of 5 million cases from 2021. Further, Pakistan reported an estimated 2.6 million cases in 2022, a notable increase from the 500,000 cases reported in 2021. Therefore, the rise in the incidence of mosquito-related diseases is driving the growth of the malaria vaccine market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

The malaria vaccines market covered in this report is segmented –
1) By Agent: Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines
3) By Route of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes
4) By Distribution Channel: Public, Private

 Major companies operating in the malaria vaccine market are developing innovative products, such as vaccines for children's malaria, to meet larger customer bases, increase sales, and increase revenue. Vaccines for mosquito-borne diseases are immunological formulations designed to protect against illnesses transmitted by mosquitoes. It is a pediatric vaccine against Plasmodium falciparum, the deadliest malaria parasite globally and the most prevalent in Africa. For instance, in November 2022, Malawi, a country in East Africa, and the World Health Organization, a Switzerland-based intergovernmental organization, launched Africa's first children's malaria vaccine. The distinctive characteristic of the RTSS vaccine, designed for young children, is its potential to decrease mortality from the mosquito-borne disease. Having undergone pilot testing on over one million children in Ghana, Kenya, and Malawi, the vaccine, despite a modest effectiveness rate of 30%, has instilled optimism that it could save lives among the 400,000 individuals who succumb to malaria each year.

The malaria vaccines market report table of contents includes:
1. Executive Summary

2. Malaria Vaccines Market Characteristics

3. Malaria Vaccines Market Trends And Strategies

4. Malaria Vaccines Market - Macro Economic Scenario

5. Global Malaria Vaccines Market Size and Growth
.
32. Global Malaria Vaccines Market Competitive Benchmarking

33. Global Malaria Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Malaria Vaccines Market

35. Malaria Vaccines Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model